<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01831128</url>
  </required_header>
  <id_info>
    <org_study_id>FACE 001</org_study_id>
    <nct_id>NCT01831128</nct_id>
  </id_info>
  <brief_title>French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS)</brief_title>
  <acronym>FACE</acronym>
  <official_title>Prospective Multicentre Observational French Cohort Study of Patients With Heart Failure and Central Sleep Apnoea Requiring Adaptive Servo-Ventilation (PaceWave, AutoSet CS) Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ResMed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of FACE study is to provide in routine practice complementary long-term data on
      the mortality and morbidity of Chronic Heart Failure (CHF) patients with Central Sleep Apnea
      eligible for Adaptative Servo-Ventilation (ASV) treatment (PaceWave, AutoSet CS; ResMed).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of Central Sleep Apnea (CSA) and/or Cheyne-Stokes Respiration (CSR) in
      patients with Chronic Heart Failure (HF) is 15-46% and it is associated with worse prognosis.
      Adaptative Servo-Ventilation (ASV) suppresses sleep apnoea and reduces hyperventilation, and
      is more effective than continuous positive airway pressure (CPAP) for treating CSA/CSR.
      Short-term studies show that ASV improves cardiac function and quality of life in CHF
      patients.

      The SERVE HF multinational randomized trial is assessing the effects of addition of ASV
      (PaceWave, AutoSet CS; ResMed) to optimal medical management compared with medical management
      alone in symptomatic CHF patients with altered Left Ventricular Ejection Fraction and
      predominant CSA/CSR. The FACE study is a French prospective, multicentre, observational
      cohort that will provide complementary data to SERVE HF trial by characterizing CHF
      population eligible for ASV indications and evaluating the treatment management on long term
      follow-up of CHF patients with CSA/CSR in routine practice.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first event of all cause mortality or unplanned hospitalization for worsening heart failure</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to first event of cardiovascular mortality or unplanned hospitalization for worsening heart failure</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to first event of all cause mortality or all cause hospitalization</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time until death</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to non cardiovascular death</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to cardiovascular death</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to hospitalization due to deterioration of heart failure or cardiovascular death</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to hospitalization for other reasons or death</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to hospitalization for cardiovascular cause or cardiovascular death</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in CHF stage by evaluating NYHA (New York Heart Association) class as compared to baseline</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Quality Of Life by measuring Minnesota score as compared to baseline</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in LVEF (Left Ventricular Ejection Fraction) as compared to baseline</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Heart Rhythm as compared to baseline</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Systolic and diastolic Blood Pressure</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in AHI (Apnea Hypopnea Index) as compared to baseline</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in renal function as compared to baseline</measure>
    <time_frame>2 years</time_frame>
    <description>Estimated GFR (eGFR) will be calculated using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in BNP (B-type Natriuretic Peptide) rates as compared to baseline</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Daytime Sleepiness by measuring Epworth scale as compared to baseline</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ASV Compliance</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in medical treatment as compared to baseline</measure>
    <time_frame>2 years</time_frame>
    <description>Medication consumption and use of cardiac implant will be reported</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Chronic Heart Failure</condition>
  <condition>Central Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>ASV Treatment</arm_group_label>
    <description>AutoSet CS, PaceWave</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>No ASV treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ASV Treatment</intervention_name>
    <arm_group_label>ASV Treatment</arm_group_label>
    <other_name>PaceWave</other_name>
    <other_name>AutoSet CS</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic Heart Failure Patients with Central Sleep Apnea
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult Patient with Chronic Heart Failure

          -  Central Sleep Apnea requiring ASV therapy

        Exclusion Criteria:

          -  Contra-indications to ASV therapy

          -  Respiratory Failure or Hypercapnia inconsistent with ASV therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Pia d'ORTHO, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP (Assistance Publique HÃ´pitaux de Paris) - Bichat-Claude Bernard Hospital, Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Louis PEPIN, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Grenoble University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Marc DAVY, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Arnaud de Villeneuve University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thibaud DAMY, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>APHP - Henri Mondor University Hospital, Creteil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick LEVY, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Grenoble University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Renaud TAMISIER, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Grenoble University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurent MORIN, PhD</last_name>
    <phone>(0)426100200</phone>
    <phone_ext>33</phone_ext>
    <email>laurent.morin@resmed.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical practice of cardiology</name>
      <address>
        <city>AmnÃ©ville Les thermes</city>
        <zip>57360</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Antibes Hospital</name>
      <address>
        <city>Antibes</city>
        <zip>06160</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>BÃ©ziers Hospital</name>
      <address>
        <city>Beziers</city>
        <zip>34500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cannes Hospital</name>
      <address>
        <city>Cannes</city>
        <zip>06400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Henri-Mondor University Hospital</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Le Mans Hospital</name>
      <address>
        <city>Le Mans</city>
        <zip>72037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>HCL - Croix-Rousse Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jacques Cartier Hospital</name>
      <address>
        <city>Massy</city>
        <zip>91300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Arnaud de Villeneuve University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nevers Hospital</name>
      <address>
        <city>Nevers</city>
        <zip>58033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>APHP - PitiÃ©-SalpÃªtriÃ¨re University Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>APHP - Bichat-Claude Bernard Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marie-Pia d'ORTHO, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Poitiers University Hospital</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint Laurent Polyclinic</name>
      <address>
        <city>Rennes</city>
        <zip>35706</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toulouse University Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2013</study_first_submitted>
  <study_first_submitted_qc>April 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2013</study_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Congestive Heart Failure</keyword>
  <keyword>Central Sleep Apnea</keyword>
  <keyword>Sleep-Disordered Breathing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

